Beijing, Mar 5 (Prensa Latina) Cooperation in the field of biotechnology between China and Cuba is showing a new achievement with the signing here of the project to invest in the first joint park to research, develop, produce and commercialize products in the Caribbean island.
According to Cuban Ambassador Carlos Miguel Pereira, Guangxi Fukang Medical Investment and Management Co Ltd and authorities from the Fangchenggang Development Zone signed the agreement on Monday.
That step followed a meeting in December 2019 between Marta Ayala, joint general director of the Genetic Engineering and Biotechnology Center (CIGB), with Fangchenggang Mayor Ban Zhongbo and other local leaders.
The project includes the construction of a cooperative platform to provide better services in public health, and a joint venture that will make Cuban medicines to treat heart and cerebral-vascular diseases, different kinds of cancer, and chronic hepatitis B, among others.
The project resulted from a recent agreement between the group BioCubaFarma and Guangxi Fukang Medical Investment and Management Co Ltd.
‘The Fangchenggang pilot zone, which is connected with the countries of the Association of South East Asian Nations (ASEAN) by land and sea, offers us good opportunities and confirms that bilateral cooperation in the field of biotechnology has solid foundations,’ Ayala said at the time.